Bemarituzumab
Modify Date: 2024-01-02 16:04:43
Bemarituzumab structure
|
Common Name | Bemarituzumab | ||
|---|---|---|---|---|
| CAS Number | 1952272-74-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BemarituzumabBemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research[1]. |
| Name | Bemarituzumab |
|---|
| Description | Bemarituzumab is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |